Obesity Management Global Market 2019 by Most Eminent Players like Pfizer Inc., Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., F. Hoffmann-La Roche Ltd Etc.

Industry Report for “Global Obesity Management Market” by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the industry performance.

Obesity Management Market - Scenario

In 2014, World Health Organization (WHO) stated that approximately 41 million children under who age under 5 were estimated to be overweight or obese. Moreover, it was estimated that approximately 600 million adults were obese within the same year.

Obesity is characterized as a disease in which patients’ body can gain excessive fat. This generates a negative impact on the patient’s health. However, the disease is considered to be manageable by changing the lifestyle and adopting healthy habits.

Obesity management and related chronic condition requires a highly motivated patient and committed healthcare professionals.

GET FREE SAMPLE COPY OF REPORT @ https://www.marketresearchfuture.com/sample_request/2690

Leading Key Players

Apollo Endosurgery (USA)

AstraZeneca (UK)

Ethicon, Inc. (USA)

Hoffmann-La Roche Ltd (Switzerland)

GlaxoSmithKline PLC (UK)

Herbalife Ltd. (USA)

Merck Sharp & Dohme Corp.,

A subsidiary of Merck & Co., Inc. (USA)

Pfizer Inc. (USA)

Global Obesity Management Market - Growth and Analysis

The key factors driving the market include easily accessible takeaway meals, growing awareness of weight management techniques, growing initiatives by the market players in collaboration, growing initiatives by government to raise awareness about the adverse impact of obesity on health, growth in nuclear families, growing patient population, increasing demand for inexpensive fast food, research and development (R & D) activities, and rising working population.

However, the availability of low-cost alternatives, the high cost of customization, and post-surgical side effects are the major restraining factors affecting the market growth.

Detailed Market Segment Analysis

The global obesity management market has been segmented on the basis of lifestyle changes, prescription weight-loss medication, surgery, and lastly region. Based on lifestyle changes, this market has been segmented into dietary changes, exercise, and others.

Prescription weight-loss medication based segmentation segments the market into buproprion & naltrexone (Contrave), lorcaserin (Belviq), orlistat (Xenical), phentermine & topiramate (Qsymia), liraglutide (Saxenda), and others.

On the basis of surgery, the market has been segmented into biliopancreatic diversion with duodenal switch, gastric bypass surgery, laparoscopic adjustable gastric banding (LAGB), and others.

BROWSE PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/obesity-management-market-2690

Global Obesity Management Market – Regional Analysis

The global obesity management market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the Global Obesity Management Market due to better accessibility to healthcare services, high healthcare expenditures, a well-developed healthcare sector, and a huge obese population. Moreover, the presence of developed economies like the U.S. and Canada. The Americas for obesity management is segmented into North America and South America. North America leads the market while South America is estimated to be the fastest growing region.

Europe stands second in the Global Obesity Management Market and is estimated to be followed by Asia Pacific. Huge patient population, increasing research and development expenses, and increasing awareness for the medical condition drives the market growth within Europe.

Asia Pacific region is estimated to be the fastest growing for the Global Obesity Management Market. This can be attributed to the presence of developing economies like India and China, a developing healthcare sector, growing healthcare industries within the region.

However, the Middle East & Africa is estimated to hold the least market share of the market owing to the presence poor economies and stringent government policies within the African region.

Europe is the second largest regional market for obesity management. Due to the reasons same as the Americas, Western Europe is a bigger market than Eastern Europe. In Western Europe, the biggest markets are France, Germany, Italy, Spain, and the United Kingdom (UK).

The Asia Pacific market is the third largest market. Due to the high population in China and India, junk food brands have a huge market here. So obesity management always has a huge demand in these countries. Other important country-specific markets in the Asia Pacific are Japan and South Korea, followed by the rest of the Asia Pacific region.

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.